Presentation is loading. Please wait.

Presentation is loading. Please wait.

New England District Update

Published byΚύρα Βονόρτας Modified over 5 years ago

Similar presentations

Presentation on theme: "New England District Update"— Presentation transcript:

1 New England District Update
MassMEDIC Conference December 2, 2009 Waltham, MA

2

3 New Hires 33 Consumer Safety Officers
4 Supervisory Consumer Safety Officers 3 Compliance Officers 3 Consumer Safety Technicians

4 New Hires District Director Director Investigations Branch
Regional & Local Quality System Manager Regional & Local State Contract/Emergency Coordinator

5 Currently Investigations 9 SCSO 102 CSOs/CSIs

6 Currently Compliance 10 CO’s 1 FOI Specialist

7 Inventory 8897 establishments 2892 device firms

8 Accomplishments 1216 Inspections 254 Device inspections
21 Foreign inspections

9 Recalls FY 08 118 Total 56 Device 4 Class I 48 Class II 4 Class III

10 Compliance Actions 16 Warning Letters 4 Device QSRs
1 Indictment of firm & executives for fraudulent marketing scheme Wire fraud Conspiracy Misbranding False statements to FDA If guilty Firm > $500,000 fine or 2x’s gross gain Executives 20 yrs prison + fine > $250,000 or 2x’s gross gain

11 Compliance Actions 63 lines of imported devices detained

12 FY10 Device Workplan INSPECTIONAL TYPE NWE-DO (domestic/foreign) ORA
QSR 171 / 22 1859 / 286 PMA 14 / 5 169 / 53 BIMO 21 / 2 320 / 15 TOTAL 204 / 29 2225 / 354

13 Commissioner’s Enforcement Initiatives August 6 2009
Post inspection deadlines (for EI’s o/a 9/15/09) FR Vol. 74, No. 153, 8/11/09, – 40212 15 days to provide 483 response Streamline Warning Letter process OCC review limited to significant legal issues Collaboration with regulatory partners State, local, international officials can act quicker

14 Commissioner’s Enforcement Initiatives August 6 2009
Prioritize follow-up on enforcement actions Inspection to ensure corrective actions Root cause identified Take immediate action in response to public health risks FDA will act quickly and aggressively on public health concerns Implement a formal Warning Letter “close-out” process After FDA determines violations have been corrected notice will be posted on FDA website For WL issued after 9/1/09

Download ppt "New England District Update"

Similar presentations

FDA Medical Device Update

FDA Medical Device Update
Medical Device Law. FDA FDA Regulated Devices From the Beginning Hubbard Electrometer Cases Magnetic Healing Cases Original Law Required Proof of Harm.

Medical Device Law. FDA FDA Regulated Devices From the Beginning Hubbard Electrometer Cases Magnetic Healing Cases Original Law Required Proof of Harm.
FDA Import Operations Embassy Training Seminar Presented by Carl R. Nielsen Director, Div. of Import Operations & Policy November 7, 2003.

FDA Import Operations Embassy Training Seminar Presented by Carl R. Nielsen Director, Div. of Import Operations & Policy November 7, 2003.
Determining the Regulatory Pathway to Market Classification Heather S. Rosecrans Director, 510(k) Staff Office of Device Evaluation Center for Devices.

"Determining the Regulatory Pathway to Market" Classification Heather S. Rosecrans Director, 510(k) Staff Office of Device Evaluation Center for Devices.
August 21, 2012 Western Regional Gas Conference Paul Gustilo Southwest Gas Corporation.

August 21, 2012 Western Regional Gas Conference Paul Gustilo Southwest Gas Corporation.
Funding Opportunities for State, Local, Tribal, and Territorial Retail Food Regulatory Programs Cathy Hosman and Pete Salsbury U.S. Food and Drug Administration.

Funding Opportunities for State, Local, Tribal, and Territorial Retail Food Regulatory Programs Cathy Hosman and Pete Salsbury U.S. Food and Drug Administration.
What’s New in the FDA’s Pharmaceutical Inspectorate and Risk Based Systems Inspection Rick Perlman Chair Food, Drug, and Cosmetic Division ASQ.

What’s New in the FDA’s Pharmaceutical Inspectorate and Risk Based Systems Inspection Rick Perlman Chair Food, Drug, and Cosmetic Division ASQ.
Focus on Quality FDA Initiative: June 11, 2013 Francisco Vicenty

Focus on Quality FDA Initiative: June 11, 2013 Francisco Vicenty
Introduction to Regulation

Introduction to Regulation
Vernon D. Toelle, Ph.D. Team Leader Pre-Market Compliance and Administrative Actions Team (BIMO Team) Overview of CVM Bioresearch Monitoring.

Vernon D. Toelle, Ph.D. Team Leader Pre-Market Compliance and Administrative Actions Team (BIMO Team) Overview of CVM Bioresearch Monitoring.
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.
MAGI's Clinical Trial Agreements, Budgets & Regulatory Conference FDA Inspections of Investigator Sites Paul Below Clinical Research Consultant P. Below.

MAGI's Clinical Trial Agreements, Budgets & Regulatory Conference FDA Inspections of Investigator Sites Paul Below Clinical Research Consultant P. Below.
FDA’s Pharmaceutical Inspectorate Robert Coleman National Expert Drug Investigator Food and Drug Administration.

FDA’s Pharmaceutical Inspectorate Robert Coleman National Expert Drug Investigator Food and Drug Administration.
Classification of HLA Devices FDA Introduction & Background Sheryl A. Kochman CBER/OBRR/DBA.

Classification of HLA Devices FDA Introduction & Background Sheryl A. Kochman CBER/OBRR/DBA.
Steve Stich Director Safety and Inspection Standard 6 Breakout Session Compliance and Enforcement Program March 12, 2014 8:00am – 12:00 pm Julie Loera.

Steve Stich Director Safety and Inspection Standard 6 Breakout Session Compliance and Enforcement Program March 12, :00am – 12:00 pm Julie Loera.
FDA Resources and Meetings FDA/EMA Orphan Designation and Grant Workshop Silver Spring, Maryland FDA Campus (White Oak) October 12, 2012 Bill Sutton Deputy.

FDA Resources and Meetings FDA/EMA Orphan Designation and Grant Workshop Silver Spring, Maryland FDA Campus (White Oak) October 12, 2012 Bill Sutton Deputy.
Are you ready for a recall? Medical Device Regulatory, Reimbursement and Compliance Congress March 28, 2007 Willie R. Bryant, Jr. Consultant Stericycle,

Are you ready for a recall? Medical Device Regulatory, Reimbursement and Compliance Congress March 28, 2007 Willie R. Bryant, Jr. Consultant Stericycle,
FDA Recalls Risk Communication Advisory Committee David K. Elder Director, Office of Enforcement.

FDA Recalls Risk Communication Advisory Committee David K. Elder Director, Office of Enforcement.
Regulatory Update Ellen Leinfuss SVP, Life Sciences.

Regulatory Update Ellen Leinfuss SVP, Life Sciences.
Ensuring Quality in Medical Device Clinical Trials

Ensuring Quality in Medical Device Clinical Trials

Similar presentations

Ads by Google